Global Blood Plasma Market to expand with 10.18% CAGR through 2023

November 15, 2019


According to research report titled ‘Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)’ available with Market Study Report LLC, the global blood plasma market is expected to grow substantially with a CAGR of 10.18% during the period of 2018-2023.
 

For the record, blood plasma is a yellow colored liquid present in artilleries which facilitate in holding and transferring blood cells throughout the body. It plays a significant role in providing immunity to the body from diseases and other blood disorders by balancing the electrolyte concentration in the intravascular osmotic systems.
 

Growing adoption of plasma-based medical products, coupled with rising awareness regarding plasma donation will drive the growth of blood plasma market. The market is expected to expand further due to introduction of specialized products. Surging geriatric population, and surging investments in healthcare infrastructure for diseases namely, neurological disorders, immunodeficiency, and clotting disabilities will further assist in augmenting the blood plasma market outlook.
 

As per product type, the blood plasm market is divided into albumin, immunoglobulins (IV+SC), and factor VIII (plasma derived).
 

Considering the geographical landscape, the market is fragmented into regions namely, Europe, North America, APAC and rest of the world, with primary focus on nations of Canada, US, Germany, Italy, France, Japan, China, Southeast Asia, India, and Australia. According to the report, North America dominated the global blood plasma market in 2018, due to high collection of source plasma for the process of fractionation.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1290090/
 

The key players in the blood plasma market are Baxter International, CSL Limited, Octa Pharma, Grifols SA, Antaris Pharma, Emergent Bio-solutions, Biota Pharma, AMAG Pharma, Biotest AG, and Bio-delivery Science International.
 

Notably, the research report discusses and examines the potential growth opportunities in blood plasma market. It also provides crucial statistics on revenue shares for each segment. The study further aims to deliver top-notch business information and help investors to evaluate their investments thoroughly.


Frequently Asked Questions (FAQ) :

Growing adoption of plasma-based medical products, coupled with rising awareness regarding plasma donation will drive the growth of blood plasma market. The market is expected to expand further due to introduction of specialized products. Surging geriatric population, and surging investments in healthcare infrastructure for diseases namely, neurological disorders, immunodeficiency, and clotting disabilities will further assist in augmenting the blood plasma market outlook.
The global blood plasma market is expected to grow substantially with a CAGR of 10.18% during the period of 2018-2023.
North America holds the largest regional share in the blood plasma market presently, due to high collection of source plasma for the process of fractionation.
The key players in the blood plasma market are Baxter International, CSL Limited, Octa Pharma, Grifols SA, Antaris Pharma, Emergent Bio-solutions, Biota Pharma, AMAG Pharma, Biotest AG and Bio-delivery Science International.